Dr. Klein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3030 Childrens Way
San Diego, CA 92123Phone+1 858-966-4032Fax+1 858-966-6227- Is this information wrong?
Education & Training
- National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 1988 - 1990
- Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1985 - 1988
- Pennsylvania State University College of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1993 - 2024
- DE State Medical License 1994 - 2003
- NJ State Medical License 1999 - 2001
- PA State Medical License 1986 - 2000
- MD State Medical License 1988 - 1999
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty Start of enrollment: 2015 Aug 31
Publications & Presentations
PubMed
- Timing of onset of menses after GnRH agonist treatment for central precocious puberty.Marcela Vargas Trujillo, Sanja Dragnic, Stephen Van Komen, Moming Li, Karen O Klein, Peter A Lee> ;Journal of Pediatric Endocrinology & Metabolism. 2024 Apr 15
- Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty.Marcela Vargas Trujillo, Peter A Lee, Kent Reifschneider, Philippe F Backeljauw, Sanja Dragnic, Stephen Van Komen, Jun Yu, Karen O Klein> ;Journal of Pediatric Endocrinology & Metabolism. 2023 Mar 28
- 2 citationsNo pubertal growth spurt, rapid bone maturation, and menarche post GnRHa treatment in girls with precocious puberty.Audrey Briscoe, Katherine Chen, Karen O Klein> ;Journal of Pediatric Endocrinology & Metabolism. 2022 Nov 25
- Join now to see all
Press Mentions
- Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce Commercial Availability of Triptodur(TM), Triptorelin 6-Month Formulation, FoMay 1st, 2018
- FDA: Triptorelin Slows Central Precocious PubertyJuly 10th, 2017
- FDA Approves Triptodur for Treatment of Early PubertyJune 30th, 2017
Grant Support
- Recombinant Tissue Plasminogen Activator For Treatment Of Livedoid VasculitisNational Center For Research Resources1992
Hospital Affiliations
- Rady Children's Hospital - San DiegoSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: